Literature DB >> 16402236

Communication and phase 1 clinical trial recruitment.

Martin H N Tattersall.   

Abstract

Mesh:

Year:  2006        PMID: 16402236     DOI: 10.1007/s00520-005-0010-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  7 in total

1.  Cancer clinical trial recruitment.

Authors:  Martin Tattersall
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

Review 2.  Interventions to improve research participants' understanding in informed consent for research: a systematic review.

Authors:  James Flory; Ezekiel Emanuel
Journal:  JAMA       Date:  2004-10-06       Impact factor: 56.272

3.  Quality of informed consent: a new measure of understanding among research subjects.

Authors:  S Joffe; E F Cook; P D Cleary; J W Clark; J C Weeks
Journal:  J Natl Cancer Inst       Date:  2001-01-17       Impact factor: 13.506

4.  Quality of informed consent in cancer clinical trials: a cross-sectional survey.

Authors:  S Joffe; E F Cook; P D Cleary; J W Clark; J C Weeks
Journal:  Lancet       Date:  2001-11-24       Impact factor: 79.321

5.  Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

Authors:  Thomas G Roberts; Bernardo H Goulart; Lee Squitieri; Sarah C Stallings; Elkan F Halpern; Bruce A Chabner; G Scott Gazelle; Stan N Finkelstein; Jeffrey W Clark
Journal:  JAMA       Date:  2004-11-03       Impact factor: 56.272

Review 6.  Consultation audio tapes: an underused cancer patient information aid and clinical research tool.

Authors:  Martin H N Tattersall; Phyllis N Butow
Journal:  Lancet Oncol       Date:  2002-07       Impact factor: 41.316

7.  Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients.

Authors:  M Tomamichel; C Sessa; S Herzig; J de Jong; O Pagani; Y Willems; F Cavalli
Journal:  Ann Oncol       Date:  1995-04       Impact factor: 32.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.